[HTML][HTML] Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7
The COVID-19 pandemic has had widespread effects across the globe, and its causative
agent, SARS-CoV-2, continues to spread. Effective interventions need to be developed to end …
agent, SARS-CoV-2, continues to spread. Effective interventions need to be developed to end …
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
The B.1.1.529/Omicron variant of SARS-CoV-2 was only recently detected in southern Africa,
but its subsequent spread has been extensive, both regionally and globally 1 . It is …
but its subsequent spread has been extensive, both regionally and globally 1 . It is …
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic continues,
with devasting consequences for human lives and the global economy 1 , 2 . The discovery …
with devasting consequences for human lives and the global economy 1 , 2 . The discovery …
Antibody evasion by SARS-CoV-2 Omicron subvariants BA. 2.12. 1, BA. 4 and BA. 5
SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 have surged notably to become
dominant in the United States and South Africa, respectively 1 , 2 . These new subvariants …
dominant in the United States and South Africa, respectively 1 , 2 . These new subvariants …
[PDF][PDF] Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization
The emergence of SARS-CoV-2 variants has raised concerns about altered sensitivity to
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B.1.1.7 and B.…
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B.1.1.7 and B.…
[PDF][PDF] Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
Numerous antibodies that neutralize SARS-CoV-2 have been identified, and these generally
target either the receptor-binding domain (RBD) or the N-terminal domain (NTD) of the viral …
target either the receptor-binding domain (RBD) or the N-terminal domain (NTD) of the viral …
Antigenicity and receptor affinity of SARS-CoV-2 BA. 2.86 spike
A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant, BA.2.86,
has emerged and spread to numerous countries worldwide, raising alarm because its …
has emerged and spread to numerous countries worldwide, raising alarm because its …
Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation
P Vasudevan, MKM Nair, T Annamalai… - Veterinary …, 2003 - Elsevier
Staphylococcus aureus is one of the most common pathogens responsible for contagious
mastitis in ruminants. The ability of S. aureus to form biofilm in vivo is considered to be a major …
mastitis in ruminants. The ability of S. aureus to form biofilm in vivo is considered to be a major …
Defining the risk of SARS-CoV-2 variants on immune protection
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants jeopardizes the protective antiviral immunity induced after infection or …
variants jeopardizes the protective antiviral immunity induced after infection or …
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants
Ethnopharmacological relevance Artemisia annua L. has been used for millennia in Southeast
Asia to treat “fever”. Many infectious microbial and viral diseases have been shown to …
Asia to treat “fever”. Many infectious microbial and viral diseases have been shown to …